BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2188774)

  • 1. Morphine and oxycodone hydrochloride in the management of cancer pain.
    Kalso E; Vainio A
    Clin Pharmacol Ther; 1990 May; 47(5):639-46. PubMed ID: 2188774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.
    Wiffen PJ; Derry S; Moore RA
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD011056. PubMed ID: 24874470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Oxycodone Hydrochloride in Treating Radiotherapy-Related Pain.
    Wang Y; Xing L
    Pain Res Manag; 2020; 2020():7565962. PubMed ID: 32089760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of oxycodone hydrochloride sustained-release tablets and morphine hydrochloride sustained-release tablets on peripheral blood T cell levels in advanced lung squamous cell carcinoma with moderate to severe cancer pain.
    Yan J; Xie ZZ; Ma N; Zheng MD; Qiao TT; Wang Y
    Pak J Med Sci; 2023; 39(5):1492-1495. PubMed ID: 37680811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Oxycodone Compared With Intravenous Morphine Sulfate for Pain Management of Isolated Limb Trauma; a Randomized Clinical Trial.
    Eizadi P; Jalili M; Dehpour A
    Emerg (Tehran); 2018; 6(1):e59. PubMed ID: 30584575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Not Available].
    Nielsen AVA; Aædder EA; Uhrbrand PG; Runge C; Breining P
    Ugeskr Laeger; 2023 Sep; 185(37):. PubMed ID: 37772499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled-release oxycodone and morphine in cancer related pain.
    Heiskanen T; Kalso E
    Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
    Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
    J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia.
    Silvasti M; Rosenberg P; Seppälä T; Svartling N; Pitkänen M
    Acta Anaesthesiol Scand; 1998 May; 42(5):576-80. PubMed ID: 9605375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia.
    Watson CP; Babul N
    Neurology; 1998 Jun; 50(6):1837-41. PubMed ID: 9633737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxycodone for cancer-related pain.
    Schmidt-Hansen M; Bennett MI; Arnold S; Bromham N; Hilgart JS
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003870. PubMed ID: 25723351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC.
    Caraceni A; Hanks G; Kaasa S; Bennett MI; Brunelli C; Cherny N; Dale O; De Conno F; Fallon M; Hanna M; Haugen DF; Juhl G; King S; Klepstad P; Laugsand EA; Maltoni M; Mercadante S; Nabal M; Pigni A; Radbruch L; Reid C; Sjogren P; Stone PC; Tassinari D; Zeppetella G; ;
    Lancet Oncol; 2012 Feb; 13(2):e58-68. PubMed ID: 22300860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of morphine-induced delirium in palliative care by substitution with infusion of oxycodone.
    Maddocks I; Somogyi A; Abbott F; Hayball P; Parker D
    J Pain Symptom Manage; 1996 Sep; 12(3):182-9. PubMed ID: 8803381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study.
    Parris WC; Johnson BW; Croghan MK; Moore MR; Khojasteh A; Reder RF; Kaiko RF; Buckley BJ
    J Pain Symptom Manage; 1998 Oct; 16(4):205-11. PubMed ID: 9803047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
    Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
    J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-ranging study of oxycodone for chronic pain in advanced cancer.
    Glare PA; Walsh TD
    J Clin Oncol; 1993 May; 11(5):973-8. PubMed ID: 8487060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trial.
    Riley J; Branford R; Droney J; Gretton S; Sato H; Kennett A; Oyebode C; Thick M; Wells A; Williams J; Welsh K; Ross J
    J Pain Symptom Manage; 2015 Feb; 49(2):161-72. PubMed ID: 24975432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, double-blind, non-inferiority study of hydromorphone hydrochloride immediate-release tablets versus oxycodone hydrochloride immediate-release powder for cancer pain: efficacy and safety in Japanese cancer patients.
    Inoue S; Saito Y; Tsuneto S; Aruga E; Takahashi H; Uemori M
    Jpn J Clin Oncol; 2018 Jun; 48(6):542-547. PubMed ID: 29659913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of opioids for cancer-related pain using a biomarker: a randomized, multi-institutional, open-label trial (RELIEF study).
    Matsuoka H; Tsurutani J; Chiba Y; Fujita Y; Terashima M; Yoshida T; Sakai K; Otake Y; Koyama A; Nishio K; Nakagawa K
    BMC Cancer; 2017 Oct; 17(1):674. PubMed ID: 28985716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
    Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
    Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.